Together, our results indicate that risk variant rs57141087 brings enhancer in contact with TRIM37 promoter in cis through NRF1 binding to induce precise gene expression changes triggering neoplastic transformation and breast cancer progression (Fig. 4L). This evidence concerns the gene TRIM37 and breast cancer.